New York, NY -- (SBWIRE) -- 01/23/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Supernus Pharmaceuticals Inc (NASDAQ:SUPN), American Lorain Corporation (NYSEMKT:ALN), Emulex Corporation (NYSE:ELX), RAIT Financial Trust (NYSE:RAS)
Supernus Pharmaceuticals Inc (NASDAQ:SUPN) showed a volume of 1.45 million shares by the end of last trade whereas the average volume of the stock remained 697,445 shares. The stock opened the session at $9.22 but then moved to $9.64. At that price, the stock showed a positive performance of 4.33%. Supernus Pharmaceuticals, Inc. (Supernus) is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders.
Will SUPN Continue To Move Higher? Find Out Here
American Lorain Corporation (NYSEMKT:ALN) opened the session at $1.00 and closed the session at $1.09. The stock showed a positive performance of 7.92% in previous trading session. American Lorain Corporation (ALN) is an integrated food manufacturing company. The Company develops, manufactures and sells food products, which includes chestnut products, convenience foods, including ready-to-cook (RTC) foods, ready-to-eat (RTE) foods and meals ready-to-eat (MRE)), and frozen food products.
For How Long ALN will fight for Profitability? Read This Trend Analysis report
Emulex Corporation (NYSE:ELX) opened the session at $7.50 and closed the session at $7.61. The stock showed a positive performance of 0.26% in previous trading session. The beta of the stock remained 1.96. Emulex Corporation (Emulex) is a provider of a range of network convergence solutions that connect servers, storage, and networks within the data center. The Company’s product portfolio includes Host Bus Adapters (HBAs), Converged Network Adapters (CNAs),
Why Should Investors Buy ELX After The Recent Gain? Just Go Here and Find Out
RAIT Financial Trust (NYSE:RAS) the stock decreased -0.12% and finished the session at $8.47. Traded with volume of 1.43 million shares in the prior session and the average volume of the stock remained 1.34 million shares. The beta of the stock remained 3.62. RAIT Financial Trust (RAIT) is a self-managed and self-advised real estate investment trust (REIT). RAIT is a vertically integrated commercial real estate company with a commercial real estate focused platform capable of originating primarily commercial real estate loans,
Will RAS Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)